Blood components: current challenges.
Labile blood products are still here to stay for quite a long time. All European surveys come in agreement to reveal that indications, extremely heterogeneous from one country to another, are not fully under control. Both the EuroNet-TMS network and Euro'SAT congresses aim at improving the use of such products within an evidence-based medicine perspective.
Rouger
P
P
Institut national de la transfusion sanguine (INTS), 6 rue Alexandre-Cabanel, Paris cedex 15, France. prouger@ints.fr
D001688:Biological Products / Q000592:standards*; D001781:Blood Component Removal / Q000706:statistics & numerical data; D001803:Blood Transfusion / Q000592:standards*; D005060:Europe; D005062:European Union; D006801:Humans
D001688:Biological Products